Clinical Trials in San Antonio

Showing 8361-8380 of 14,633 trials

Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System

NCT04645641

Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System

DexCom, Inc.150 participantsStarted Oct 2020

Escondido, California, United States • Aurora, Colorado, United States • Idaho Falls, Idaho, United States +1 more locations

UNKNOWNPhase 1< 1 mile

A Study of PSB205 in Subjects With Advanced Solid Tumors

NCT03986606

This is an open-label, multicenter, Phase 1, ascending dose escalation study of PSB205 in subjects with advanced solid tumors. The study will be conducted in 2 parts. Part 1 of the study will be a dose escalation evaluation to determine the maximum tolerated dose (MTD) and to establish a recommended Phase 2 dose (RP2D) of PSB205. This study purpose is to describe the safety and tolerability, to assess Pharmacokinetics (PK) and immunogenicity, and to preliminarily assess the anti-tumor activity of PSB205 in subjects with solid tumors. Part 2 of the study will further evaluate the RP2D in 3 distinct tumor cohorts of approximately 12 subjects each.

Neoplasm Malignant

Qilu Puget Sound Biotherapeutics (dba Sound Biologics)64 participantsStarted Jul 2019

San Antonio, Texas, United States

COMPLETEDPhase 2< 1 mile

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

NCT00940602

This was a randomized, double-blind trial to evaluate deferasirox vs placebo in patients with myelodysplastic syndromes (low/int-1 risk) and transfusional iron overload .The trial was conducted in 17 countries, started in 2010 and ended in 2018.

Myelodysplastic Syndromes

Novartis Pharmaceuticals225 participantsStarted Mar 2010

Anaheim, California, United States • Greenwood Village, Colorado, United States • Shreveport, Louisiana, United States +68 more locations

Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System

A Study of PSB205 in Subjects With Advanced Solid Tumors

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

Find Trials by Condition in San Antonio

Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies

Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Multiple Areas of Pain (MAP)

A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A

Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)

A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).

Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada